The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease
References (21)
- et al.
Long-term results of pulmonary resection for atypical mycobacterial disease
Am Thorac Surg
(1983) - et al.
Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates
J Infect Chemother
(2006) - et al.
A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease
Respir Med
(2007) - et al.
Comparative in vitro and in vivo antimicrobial activities of sitafloxacin, gatifloxacin and moxifloxacin against Mycobacterium avium
Int J Antimicrob Agents
(2011) - et al.
Clarithromycin Study Group of France. Clarithromycin in the treatment of Mycobacterium avium patients without AIDS
Chest
(1995) Medical management of pulmonary diseases caused by Mycobacterium avium complex
Clin Chest Med
(2002)Diagnosis and treatment of disease caused by nontuberculous mycobacteria
Am J Respir Crit Care Med
(1997)- et al.
ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
Am J Respir Crit Care Med
(2007) - et al.
American Thoracic Society; Infectious Diseases Society of America. Guidelines on the diagnosis and treatment of pulmonary non-tuberculous mycobacteria infection
Int J Clin Pract
(2008) - et al.
Clarithromycin regimens for pulmonary Mycobacterium avium complex: the first 50 patients
Am J Respir Crit Care Med
(1996)
Cited by (29)
Treatment strategies with alternative treatment options for patients with Mycobacterium avium complex pulmonary disease
2022, Respiratory InvestigationCitation Excerpt :However, in clinical practice, FQs have been used as substitutes for RIF, or in cases of macrolide resistance. A prospective study comparing the efficacy and safety of gatifloxacin or CLR-containing regimens in combination with RIF and EMB showed a similar rate of culture conversion (11/13 vs. 9/14) in untreated patients with MAC-PD [89]. Therefore, the BTS guidelines recommended treatment administration of isoniazid or FQs in combination with RIF and EMB for patients with macrolide-resistant MAC-PD [62].
Tolerability, adverse events, and efficacy of treatment for Mycobacterium avium complex pulmonary disease in elderly patients
2022, Journal of Infection and ChemotherapyCitation Excerpt :Therefore, the rate of treatment success in this study was less than that in the pooled analysis, but was comparative with those in 3 studies in Japan [11,29,30]. This agreement is probably because no patients was treated with 1000 mg/day CAM and only 8.6% of patients received streptomycin in this study, similar to the 3 studies in Japan [11,29,30]. There are some limitations in this study.
Microbiologic Outcome of Interventions Against Mycobacterium avium Complex Pulmonary Disease: A Systematic Review
2018, ChestCitation Excerpt :Of these, three studies were double-blind controlled studies: Kobashi et al,38 Milanés-Virelles et al,45 and Olivier et al.61 The treatment duration of patients with MAC-PD varied greatly, from 3 months, for example, in the study of Leventhal et al,44 up to at least 24 months in the studies of Kobashi and Matsushima,39 Murray et al,47 and Jenkins et al.33 In nine studies, treatment duration was reported to be 6 months22,26-28,45 or less23,44,57,61; in 16 studies overall (or at least for a separately notified proportion of patients), treatment duration was at least 12 months.25,29-31,33,34,37-40,46,47,50,52,54,55 Six hundred eleven patients with prior NTM treatment of the total of 2,376 patients with MAC (25.7%) were identified in 24 of the 42 included studies (57.1%).
Treatment of Mycobacterium avium complex pulmonary disease
2024, Journal of the Korean Medical AssociationPharmacologic Management of Mycobacterium chimaera Infections: A Primer for Clinicians
2022, Open Forum Infectious Diseases